MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-MH-19-0022650
Curestar Pharmaceuticals Private Limited
Curestar Pharmaceuticals Private Limited - food and beverages in Korba, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹25.98 Lakh
▲ 65% YoY
Net profit · FY 2025
₹19,450
Net margin 0.7%
EBITDA · FY 2025
₹32,284
EBITDA margin 1.2%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Curestar Pharmaceuticals Private Limited
Data last updated:
Curestar Pharmaceuticals Private Limited is a private limited company based in Korba, Maharashtra, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 15 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2020PTC340654. Its GSTIN is 10AAICC7569D1ZT (Bihar).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Karuna Kumari and Sarita Sinha.
Its last annual general meeting (AGM) was held on 08 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No – 66 Ground Floor Siddharth Nr Barkat Ali Dargah Road Antop Hill, Korba, Maharashtra, India – 400037.
As per the financials filed for FY 2025, the company reported a revenue of ₹25.98 Lakh, a growth of 65% compared to the previous year. For the same year it recorded a net profit of ₹19,450 (net margin 0.7%) and EBITDA of ₹32,284 (EBITDA margin 1.2%). Revenue has grown at a compounded annual rate (CAGR) of 25% over three years.
Curestar Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0022650).
Company details
CIN U24304MH2020PTC340654
Registration Number 340654
Incorporation Date 15 June 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 08 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0022650
Recognitions & Rankings of Curestar Pharmaceuticals
Contact details
Curestar Pharmaceuticals Private Limited's registered office is in Korba, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressHouse No – 66 Ground Floor Siddharth Nr Barkat Ali Dargah Road Antop Hill, Korba, Maharashtra, India – 400037
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
To see the full contact details of Curestar Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Curestar Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Curestar Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Curestar Pharmaceuticals Private Limited, buy the company report.
Financials of Curestar Pharmaceuticals Private Limited
FY 2025 filings availableCurestar Pharmaceuticals Private Limited reported revenue of ₹25.98 Lakh (up 65% YoY) for FY 2025.
Revenue · FY 2025
₹25.98 Lakh ▲ 65%
Net profit · FY 2025
₹19,450 margin 0.7%
EBITDA · FY 2025
₹32,284 margin 1.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 65%
3 years · compounded
▲ 25%
EBITDA CAGR growth
1 year
▲ 4%
3 years · compounded
▲ 17%
Revenue has grown at a compounded annual rate (CAGR) of 25% over three years, including 65% growth in the latest year. EBITDA rose 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹32,284 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹19,450 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Curestar Pharmaceuticals Private Limited, buy the company report.
Board of directors of Curestar Pharmaceuticals Private Limited
Curestar Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Karuna Kumari | Director | 15 Jun 2020 | 6 Years 4 Months | Current |
| Sarita Sinha | Director | 15 Jun 2020 | 6 Years 4 Months | Current |
| Amitesh Chandra | Director | 26 Nov 2025 | 0 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Curestar Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Curestar Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Curestar Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 05, 2024.
Active EPFO establishments
1
GST
Curestar Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAICC7569D1ZT | Bihar | Active | 14 Sep 2020 |
To see the full GST registrations and return filing status of Curestar Pharmaceuticals Private Limited, buy the company report.
Recent activity
Curestar Pharmaceuticals Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Amitesh Chandra was appointed as Director on 26 Nov 2025.
Appointed
Amitesh Chandra was appointed as Director.
Ceased
Karuna Kumari ceased to be Director.
AGM
Curestar Pharmaceuticals Private Limited last Annual general meeting of members was held on 08 Sep 2025 as per latest MCA records.
Filing
Curestar Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Karuna Kumari was appointed as Director.
Appointed
Sarita Sinha was appointed as Director.
Incorporation
15 Jun 2020
Curestar Pharmaceuticals Private Limited was registered on 15 Jun 2020 with Roc Mumbai & aged 6 years 4 months as per MCA records.
Frequently asked questions
Curestar Pharmaceuticals is an active private limited company based in Korba, Maharashtra, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 15 June 2020 (6+ years old) and is registered under CIN U24304MH2020PTC340654.
Curestar Pharmaceuticals has 3 current directors:
- Karuna Kumari - Director
- Sarita Sinha - Director
- Amitesh Chandra - Director
The latest financial statements of Curestar Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 08 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Curestar Pharmaceuticals is 10AAICC7569D1ZT, registered in Bihar.
The CIN (Corporate Identification Number) of Curestar Pharmaceuticals is U24304MH2020PTC340654. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Curestar Pharmaceuticals was incorporated on 15 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Amitesh Chandra was appointed as Director on 26 Nov 2025. Karuna Kumari ceased to be Director on 26 Nov 2025. Karuna Kumari was appointed as Director on 15 Jun 2020. Curestar Pharmaceuticals has 4 board changes on record in total.
Yes, Curestar Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0022650).
The registered office of Curestar Pharmaceuticals is at House No – 66 Ground Floor Siddharth Nr Barkat Ali Dargah Road Antop Hill, Korba, Maharashtra, India – 400037.
Curestar Pharmaceuticals operates in the food and beverages industry, in the manufacturing segment.